D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
Nair S and Baron H Tryptophan metabolism in tuberculosis. 1973 Am. Rev. Respir. Dis. pmid:4741891
BOWER G SKIN RASH, HEPATITIS, AND HEMOLYTIC ANEMIA CAUSED BY PARA-AMINOSALICYLIC ACID. 1964 Am. Rev. Respir. Dis. pmid:14129347
David HL et al. Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine. 1969 Am. Rev. Respir. Dis. pmid:4981706
Fischer DA et al. Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases. 1968 Am. Rev. Respir. Dis. pmid:5638494
Woodley CL and Kilburn JO In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. 1982 Am. Rev. Respir. Dis. pmid:6289711
David HL Effect of O-carbamyl-D-serine on the growth of mycobacterium tuberculosis. 1970 Am. Rev. Respir. Dis. pmid:4987793
CHAVES AD et al. ETHIONAMIDE-CYCLOSERINE THERAPY FOR AMBULATORY PATIENTS WITH PULMONARY TUBERCULOSIS UNRESPONSIVE TO STANDARD DRUGS. 1963 Am. Rev. Respir. Dis. pmid:14045232
Heifets L Qualitative and quantitative drug-susceptibility tests in mycobacteriology. 1988 Am. Rev. Respir. Dis. pmid:3195815
Hawkins JE and McClean VR Effect of d-alanine on cycloserine blood levels in laboratory animals. 1966 Am. Rev. Respir. Dis. pmid:5910683
WOLINSKY E and KAPUR VN Evaluation of cycloserine with high dosage of isoniazid in chronic treatment-failure pulmonary tuberculosis. 1959 Am. Rev. Respir. Dis. pmid:13845748
Hawkins JE and McClean VR Comparative studies of cycloserine inhibition of mycobacteria. 1966 Am. Rev. Respir. Dis. pmid:4956240
HOEPRICH PD ALANINE--CYCLOSERINE ANTAGONISM. V. OCCURRENCE AMONG ACID-FAST BACILLI. 1964 Am. Rev. Respir. Dis. pmid:14225973
Schmidt JD et al. Cutaneous infection due to a Runyon group 3 atypical Mycobacterium. 1972 Am. Rev. Respir. Dis. pmid:5080716
HOK TT and SENG TK A COMPARATIVE STUDY OF THE SUSCEPTIBILITY TO STREPTOMYCIN, CYCLOSERINE, VIOMYCIN, AND KANAMYCIN OF TUBERCLE BACILLI FROM 100 PATIENTS NEVER TREATED WITH CYCLOSERINE, VIOMYCIN, OR KANAMYCIN. 1964 Am. Rev. Respir. Dis. pmid:14233803
Ramirez J Pulmonary alveolar proteinosis. Treatment in a case complicated by tuberculosis. 1967 Am. Rev. Respir. Dis. pmid:6066626
SCHLESS JM et al. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS. 1965 Am. Rev. Respir. Dis. pmid:14280946
RIVERA E and BROWNING RH Re-treatment therapy with cycloserine-pyrazinamide. Response in cavity closure and disappearance of tubercle bacilli from sputum. 1962 Am. Rev. Respir. Dis. pmid:13974134
CONN HO et al. ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE. 1964 Am. Rev. Respir. Dis. pmid:14221666
Kuze F Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. 1984 Am. Rev. Respir. Dis. pmid:6703503
HAAPANEN J et al. Retreatment of pulmonary tuberculosis. Experiences with various combinations of pyrazinamide, cycloserine, and kanamycin in patients excreting tubercle bacilli resistant to both streptomycin and isoniazid. 1960 Am. Rev. Respir. Dis. pmid:13710174
STOREY PB A comparison of isoniazid-cycloserine with isoniazid-PAS in the therapy of cavitary pulmonary tuberculosis. X. A report of the Veterans Administration-Armed Forces cooperative study. 1960 Am. Rev. Respir. Dis. pmid:13834976
LEITES V Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy. 1959 Am. Rev. Respir. Dis. pmid:13670395
David HL Susceptibility of mycobacterium intracellulare to O-carbamyl-D-serine. 1970 Am. Rev. Respir. Dis. pmid:5427392
Yaroshenko DV et al. Development and validation of a LC-MS/MS method for D-cycloserine determination in human plasma for bioequivalence study. 2014 Anal Bioanal Chem pmid:24337137
Mao Z et al. A simplified LC-MS/MS method for rapid determination of cycloserine in small-volume human plasma using protein precipitation coupled with dilution techniques to overcome matrix effects and its application to a pharmacokinetic study. 2017 Anal Bioanal Chem pmid:28224247
Jamindar D and Gutheil WG A liquid chromatography-tandem mass spectrometry assay for Marfey's derivatives of L-Ala, D-Ala, and D-Ala-D-Ala: application to the in vivo confirmation of alanine racemase as the target of cycloserine in Escherichia coli. 2010 Anal. Biochem. pmid:19748470
el-Sayed L et al. Spectrophotometric and spectrofluorimetric determination of cycloserine with p-benzoquinone. 1986 Analyst pmid:3766980
Fountoulakis KN The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions. 2010 Ann Gen Psychiatry pmid:20385020
Nusca A et al. [Tryptose sulphite cycloserine agar for the recovery of Clostridium perfringens in surface waters: a study of different modes of utilization]. 2007 Jan-Feb Ann Ig pmid:17405507
Hermier J et al. [Role of nicotinamide adenine dinucleotide dehydrogenases in initial phase of spore germination in Bacillus subtilis]. 1970 Ann Inst Pasteur (Paris) pmid:4987262
GROSSET J and CANETTI G [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)]. 1962 Ann Inst Pasteur (Paris) pmid:13902273
TISON F et al. [UNSUITABILITY OF THE BASIC COLETSOS MEDIUM FOR THE MEASUREMENT OF SENSITIVITY TO CYCLOSERINE. INACTIVATION OF CYCLOSERINE BY SODIUM PYRUVATE]. 1963 Ann Inst Pasteur Lille pmid:14202532
LUCCHESI M et al. [ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS]. 1963 Ann Ist Carlo Forlanini pmid:14122048
Lucchesi M et al. [On some aspects of antimycobacterial activity in vitro of cycloserine and terizidone]. 1968 Ann Ist Carlo Forlanini pmid:4981145
DE SIMONI G and CATTANEO C [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin]. 1962 Ann Ist Carlo Forlanini pmid:14026068
Lucchesi M et al. [Drug sensitivity of the so-called atypical mycobacteria]. 1968 Ann Ist Carlo Forlanini pmid:4314838
MORELLINI M et al. [The activity of cycloserine on "paratubercular" mycobacteria]. 1960 Ann Ist Carlo Forlanini pmid:13772514
Boccitto G et al. [Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion]. 1968 Ann Ist Carlo Forlanini pmid:5735705
MERENDA P and FORTUNI M [On the diagnostic possibilities of cycloserine hyperthermia and aldolase activity of the serum in patients with solitary lung nodules]. 1962 Ann Ital Chir pmid:13934961
Rajtar-Leontiew Z [Effect of isoniazid on pyridoxine (vitamin B6) metabolism in children. Experimental study]. 1970 Ann Pediatr (Paris) pmid:5513157
Vamvakides A [Inactivity of imipramine in the forced swimming test on old mice or on young mice undergone chronic glycinergic treatment]. 1996 Ann Pharm Fr pmid:9008899
Peloquin CA et al. Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditions. 2001 Ann Pharmacother pmid:11724078
FLOCH H and FLOCH T [THE CHEMOTHERAPY OF LEPROSY]. 1964 Ann Soc Belges Med Trop Parasitol Mycol pmid:14211530
Srednicka-Zajac D et al. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis]. 1967 Ann Univ Mariae Curie Sklodowska Med pmid:4308440
van Dongen JT et al. Transcript and metabolite profiling of the adaptive response to mild decreases in oxygen concentration in the roots of arabidopsis plants. 2009 Ann. Bot. pmid:18660497
Venho VM and Koskinen R The effect of pyrazinamide, rifampicin and cycloserine on the blood levels and urinary excretion of isoniazid. 1971 Ann. Clin. Res. pmid:5156629
Aukee S et al. Drug absorption in patients with T-tube after cholecystectomy. 1975 Ann. Clin. Res. pmid:1155910
Murty MV and Venkitasubramanian TA Evidence for the synthesis of peptidoglycan by spheroplasts of Mycobacterium smegmatis ATCC-14468. 1984 May-Jun Ann. Microbiol. (Paris) pmid:6465738
Pyle MM Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation. 1966 Ann. N. Y. Acad. Sci. pmid:5220243
de Repentigny J and Mathieu LG Metabolism and pathogenicity in Staphylococcus single and mixed cultures and infections. 1974 Ann. N. Y. Acad. Sci. pmid:4213698